| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE | 15266 |
| 1 | FENTANYL | 14362 |
| 2 | MORPHINE SULFATE | 13942 |
| 3 | OXYCODONE HYDROCHLORIDE | 13689 |
| 4 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 12893 |
| 5 | FENTANYL CITRATE | 12452 |
| 6 | HYDROMORPHONE HYDROCHLORIDE | 12107 |
| 7 | HYDROCODONE BITARTRATE | 11425 |
| 8 | TAPENTADOL HYDROCHLORIDE | 11347 |
| 9 | BUPRENORPHINE | 11216 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYMORPHONE HYDROCHLORIDE | 2980 | 0.4793 |
| 1 | TAPENTADOL HYDROCHLORIDE | 11347 | 0.4485 |
| 2 | BUPRENORPHINE | 11216 | 0.3938 |
| 3 | FENTANYL CITRATE | 12452 | 0.3763 |
| 4 | PROTAMINE SULFATE | 454 | 0.3358 |
| 5 | HYDROMORPHONE HYDROCHLORIDE | 12107 | 0.3043 |
| 6 | PARICALCITOL | 3440 | 0.2684 |
| 7 | DOLASETRON MESYLATE | 267 | 0.2560 |
| 8 | OSIMERTINIB | 1573 | 0.2504 |
| 9 | DEFIBROTIDE SODIUM | 135 | 0.2500 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 3084 |
| 1 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1292 |
| 2 | Tetracycline-class Drug [EPC] | 526 |
| 3 | Purine Antimetabolite [EPC] | 455 |
| 4 | Stimulant Laxative [EPC] | 423 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 269 |
| 6 | Antiarrhythmic [EPC] | 85 |
| 7 | Anti-coagulant [EPC] | 22 |
| 8 | Direct Thrombin Inhibitor [EPC] | 22 |
| 9 | GLP-2 Analog [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin B6 Analog [EPC] | 4 | 0.0533 |
| 1 | Stimulant Laxative [EPC] | 423 | 0.0451 |
| 2 | GLP-2 Analog [EPC] | 16 | 0.0264 |
| 3 | Anti-coagulant [EPC] | 22 | 0.0222 |
| 4 | Insulin Analog [EPC] | 3084 | 0.0187 |
| 5 | Antiarrhythmic [EPC] | 85 | 0.0175 |
| 6 | Tetracycline-class Drug [EPC] | 526 | 0.0173 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1292 | 0.0159 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 269 | 0.0154 |
| 9 | Purine Antimetabolite [EPC] | 455 | 0.0124 |